Submitted by Anonymous (not verified) on 19 June 2025 - 13:42
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 48, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 48, Status: Authorised